Lymphatic Function in Patients With a Fontan Circulation From Brazil

May 18, 2020 updated by: University of Aarhus

Lymphatic Function and Interstitial Fluid Filtration in Patients With a Fontan Circulation From Brazil

It is suggested that the elevated central venous pressure in patients with a Fontan circulation can provoke manifestation of lymphatic dysfunction, met as plastic bronchitis, peripheral oedema and most feared protein-losing enteropathy (PLE).

An explorative study from our department at Aarhus University Hospital revealed that the function of the lymphatic vasculature in 10 young Fontan patients with no complications was abnormal compared to healthy controls. However, to further describe and confirm these findings we had to investigate the lymphatic circulation in a larger, older and more complicated group of Fontan patients.

The hypothesis is that, patients with a univentricular circulation have a reduced functionality of the lymphatic vasculature and which predisposes them to developing complications such as edema and PLE.

Study Overview

Detailed Description

The study population is patients with a Fontan circulation followed at InCor Heart Institute in Sao Paolo and Ribeirão Preto, Brazil. These were matched with and group of healthy controls.

The functional state of superficial lymphatics in the lower leg will be investigated, using near infrared fluorescence (NIRF) imaging. The capillary filtration of fluid and leakiness of the capillaries will be measured using strain gauge plethysmography and the peripheral blood flow will be measured using venous occlusion plethysmography. Furthermore, plasma concentration of noradrenaline will be estimated.

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Central Denmark Region
      • Aarhus N, Central Denmark Region, Denmark, 8200
        • Aarhus University Hospital
    • Danmark
      • Aarhus C, Danmark, Denmark, 8000
        • Aarhus University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients born with a univentricular heart treated surgically with a Fontan circulation in early childhood.

Description

Inclusion Criteria:

  • Fontan circulation
  • Age above 16.

Exclusion Criteria:

  • Mental illness
  • Syndromes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Fontan Patients
Fontan patients operated at the two centres between 1991 and 2014.
.Near-infrared imaging was used to evaluate the function of the superficial lymphatic vessels in the right lower leg and foot as previously described.doi: 10.1161/CIRCIMAGING.118.008074.
Strain Gauge Plethysmography to asses capillary filtration rate og the lower limb
Control Group
Age, gender and weight matched healthy controls.
.Near-infrared imaging was used to evaluate the function of the superficial lymphatic vessels in the right lower leg and foot as previously described.doi: 10.1161/CIRCIMAGING.118.008074.
Strain Gauge Plethysmography to asses capillary filtration rate og the lower limb

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lymphatic function assessed by Near-Infrared fluorescence Imaging 1
Time Frame: 1 hour
Contraction frequency (contraction/minut)
1 hour
Lymphatic function assessed by Near-Infrared fluorescence Imaging 2
Time Frame: 1 hour
Pumping Pressure (mmHg)
1 hour
Lymphatic function assessed by Near-Infrared fluorescence Imaging 3
Time Frame: 1 hour
Packet Velocity
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Capillary Filtration Rate measured by Strain Gauge Plethysmography
Time Frame: 1 hour
Capillary Filtration Rate
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Vibeke Hjortdal, MD, PhD, Dmsc, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2018

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

May 1, 2019

Study Registration Dates

First Submitted

May 14, 2020

First Submitted That Met QC Criteria

May 18, 2020

First Posted (Actual)

May 19, 2020

Study Record Updates

Last Update Posted (Actual)

May 19, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Univentricular Heart

Clinical Trials on Near-Infrared Fluorescence imaging

Subscribe